Wang Pin-Yi, Kuo Yu-Hsuan, Sheu Ming-Jen, Kuo Hsing-Tao, Lee Wen-Ying, Kuo Yu-Ting, Wang Su-Hung
Division of Hepatogastroenterology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Division of Hematology and Oncology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Case Reports Hepatol. 2023 Aug 7;2023:4797233. doi: 10.1155/2023/4797233. eCollection 2023.
Lymphocyte-rich hepatocellular carcinoma (HCC) represents the rarest subtype among the various subgroups of HCC, and limited clinical data are available for this particular subtype. It is commonly observed as a solitary lesion and tends to present at an early stage. Histopathological examination typically reveals tumor cells infiltrated by a lymphocyte-rich background, leading to its designation as lymphoepithelioma-like HCC. Unlike other lymphoepithelioma-like tumors associated with the Epstein-Barr virus (EBV), lymphocyte-rich HCC is predominantly negative for EBV. This subtype is characterized by more favorable clinical outcomes and prognosis compared to conventional HCC. Here, we present a case of lymphocyte-rich hepatocellular carcinoma (HCC) characterized by the presence of bilateral hepatic tumors and concurrent multiple lymphadenopathy. Interestingly, contrary to previous literature, the examination for the Epstein-Barr virus (EBV) revealed a positive result in this particular case.
淋巴细胞丰富型肝细胞癌(HCC)是HCC各亚组中最罕见的亚型,关于这一特殊亚型的临床数据有限。它通常表现为单个病灶,且往往在早期出现。组织病理学检查通常显示肿瘤细胞浸润于富含淋巴细胞的背景中,因此被命名为淋巴上皮瘤样HCC。与其他与爱泼斯坦-巴尔病毒(EBV)相关的淋巴上皮瘤样肿瘤不同,淋巴细胞丰富型HCC主要为EBV阴性。与传统HCC相比,该亚型具有更良好的临床结局和预后。在此,我们报告一例淋巴细胞丰富型肝细胞癌(HCC),其特征为双侧肝肿瘤及同时并发多处淋巴结病。有趣的是,与既往文献相反,该病例的爱泼斯坦-巴尔病毒(EBV)检测结果呈阳性。